10x Genomics, Vizgen agree to dismiss claims in monopoly suit with prejudice
MLex Summary: 10x Genomics and Vizgen have agreed to dismiss all claims with prejudice in a lawsuit over allegedly monopolizing the market for spatial transcriptomics, the companies said in a filing...To view the full article, register now.
Already a subscriber? Click here to view full article